These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 16565833

  • 21. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
    Sardão VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB.
    Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
    [Abstract] [Full Text] [Related]

  • 22. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
    Fu Z, Guo J, Jing L, Li R, Zhang T, Peng S.
    Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
    [Abstract] [Full Text] [Related]

  • 23. Protectors against doxorubicin-induced cardiotoxicity: flavonoids.
    Bast A, Kaiserová H, den Hartog GJ, Haenen GR, van der Vijgh WJ.
    Cell Biol Toxicol; 2007 Jan; 23(1):39-47. PubMed ID: 17063376
    [Abstract] [Full Text] [Related]

  • 24. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
    Alderton P, Gross J, Green MD.
    Cancer Res; 1990 Aug 15; 50(16):5136-42. PubMed ID: 2116226
    [Abstract] [Full Text] [Related]

  • 25. Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity.
    van Acker SA, Kramer K, Grimbergen JA, van den Berg DJ, van der Vijgh WJ, Bast A.
    Br J Pharmacol; 1995 Aug 15; 115(7):1260-4. PubMed ID: 7582554
    [Abstract] [Full Text] [Related]

  • 26. Acute exercise protects against doxorubicin cardiotoxicity.
    Wonders KY, Hydock DS, Schneider CM, Hayward R.
    Integr Cancer Ther; 2008 Sep 15; 7(3):147-54. PubMed ID: 18815146
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy.
    Hamed S, Barshack I, Luboshits G, Wexler D, Deutsch V, Keren G, George J.
    Eur Heart J; 2006 Aug 15; 27(15):1876-83. PubMed ID: 16731534
    [Abstract] [Full Text] [Related]

  • 32. Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity.
    Zhu J, Zhang J, Zhang L, Du R, Xiang D, Wu M, Zhang R, Han W.
    Biomed Pharmacother; 2011 Oct 15; 65(7):481-5. PubMed ID: 22000485
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
    Liu L, Shi R, Shi Q, Cheng Y, Huo Y.
    Planta Med; 2008 Feb 15; 74(3):203-9. PubMed ID: 18260050
    [Abstract] [Full Text] [Related]

  • 35. Sustained protective effects of 7-monohydroxyethylrutoside in an in vivo model of cardiac ischemia-reperfusion.
    De Celle T, Heeringa P, Strzelecka AE, Bast A, Smits JF, Janssen BJ.
    Eur J Pharmacol; 2004 Jun 28; 494(2-3):205-12. PubMed ID: 15212976
    [Abstract] [Full Text] [Related]

  • 36. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
    Li K, Sung RY, Huang WZ, Yang M, Pong NH, Lee SM, Chan WY, Zhao H, To MY, Fok TF, Li CK, Wong YO, Ng PC.
    Circulation; 2006 May 09; 113(18):2211-20. PubMed ID: 16651473
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice].
    Dai ZQ, Xu JY, Yuan XJ, Cai JC.
    Zhongguo Yao Li Xue Bao; 1996 Jan 09; 17(1):69-71. PubMed ID: 8737460
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
    Khan M, Shobha JC, Mohan IK, Naidu MU, Sundaram C, Singh S, Kuppusamy P, Kutala VK.
    Phytother Res; 2005 Dec 09; 19(12):1030-7. PubMed ID: 16372368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.